The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
JPMorgan upgraded Argan (AGX) from 'neutral' to 'overweight' with a new price target of $550.00 after the company reported Q4 EPS of $3.47, significantly beating the expected $1.99. The company also achieved Q4 revenue of $262.1 million with a net margin of 13.1% and ROE of 31.4%. This upgrade reflects the company's strong financial performance.